Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06235684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinnova-RD: A Prospective Cohort Study of Patients With Rheumatoid Diseases

Study acronym: Clinnova-RD
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Apr 1, 2026 to Oct 2026
    • Eligibility criteria expanded, about 23 words
    • Study description expanded, about 2 words
  2. Start date: Oct 1, 2024 to Apr 1, 2026v3
  3. Start date: Jun 1, 2024 to Oct 1, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is part of the Clinnova program. This is a prospective cohort study including patients with RD recruited at the time of a treatment change. At least 800 participants (recruited in France, Germany and Luxembourg) will be enrolled, of which 100 participants are expected to be recruited in Luxembourg with the present study protocol. The mission of Clinnova is to support the digitalization of healthcare and precision medicine by creating a data-enabling environment for accessing, sharing and analyzing interoperable, high-quality health data. The main hypothesis is that treatment change decided by clinicians is predictable using objective surrogate markers derived from clinical, epidemiological, and omics data. Identifying these objective markers may facilitate future treatment decisions, provide new insights on the molecular causes for differential treatment response, pathogenesis and progression, and potential pointers for improved personalized therapeutic interventions.
Trial Details
NCT Number NCT06235684
Lead Sponsor Luxembourg Institute of Health
Collaborators: Luxembourg National Research Fund, Hôpitaux Robert Schuman Luxembourg, University of Luxembourg
Conditions
(from sponsor)		 Rheumatoid Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov